Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.8701
-0.0009 (-0.10%)
At close: May 12, 2025, 4:00 PM
0.8701
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT

Cytosorbents Market Cap

Cytosorbents has a market cap or net worth of $55.72 million as of May 12, 2025. Its market cap has increased by 24.94% in one year.

Market Cap
55.72M
Enterprise Value
78.15M
1-Year Change
24.94%
Ranking
Category
Stock Price
$0.87

Market Cap Chart

Since December 31, 2007, Cytosorbents's market cap has increased from $5.50M to $55.72M, an increase of 913.15%. That is a compound annual growth rate of 14.26%.

History

DateMarket Cap% Change
May 9, 202554.40M9.24%
Dec 31, 202449.80M1.01%
Dec 29, 202349.30M-27.07%
Dec 30, 202267.60M-62.90%
Dec 31, 2021182.20M-47.05%
Dec 31, 2020344.10M175.72%
Dec 31, 2019124.80M-51.19%
Dec 31, 2018255.70M37.10%
Dec 29, 2017186.50M34.37%
Dec 30, 2016138.80M-1.77%
Dec 31, 2015141.30M-38.99%
Dec 31, 2014231.60M656.86%
Dec 31, 201330.60M11.27%
Dec 31, 201227.50M-3.17%
Dec 30, 201128.40M72.12%
Dec 31, 201016.50M43.48%
Dec 31, 200911.50M475.00%
Dec 31, 20082.00M-63.64%
Dec 31, 20075.50M-
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 659.45B
Johnson & Johnson 371.06B
UnitedHealth Group 345.29B
AbbVie 326.55B
Novo Nordisk 297.79B
Abbott Laboratories 231.82B
Novartis AG 214.71B
AstraZeneca 211.14B
Market Cap Rankings